BOTHELL, Wash.--(BUSINESS WIRE)--Helix BioMedix, Inc. (OTCBB:HXBM), a biopharmaceutical company with an extensive library of diverse bioactive peptides, today announced the appointment of Robin Carmichael as its Vice President of Marketing and Business Development. Reporting to the Chief Executive Officer, Carmichael will be responsible for the company’s marketing and business development functions, including product strategy, technology licensing, organizational management and strategic partnerships. Carmichael’s appointment will be effective October 31, 2007.
